Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Prepping the crowd

Crowd-funding could ramp in fall 2013 when SEC allows private deal marketing

Prepping the crowd

A handful of firms are not waiting for SEC to completely figure out how to implement crowd-funding provisions mandated by the JOBS Act, and are lining up to play the role of matchmaker for

Read the full 361 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers